CIK cell therapy is an adoptive immunotherapy approach where T cells are expanded with cytokines, such as IL-2 and IFN-γ, to generate highly cytotoxic lymphocytes capable of targeting and killing tumor cells (116). Here, IL2 is linked to neoplasm.